Enzymatica Publ (Sweden) Buy Hold or Sell Recommendation
| ENZY Stock | SEK 1.74 0.07 4.19% |
Assuming the 90 days trading horizon and your bold attitude towards risk, our recommendation regarding Enzymatica publ AB is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Enzymatica publ AB given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Enzymatica publ AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Enzymatica Publ Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Enzymatica and provide practical buy, sell, or hold advice based on investors' constraints. Enzymatica publ AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Enzymatica |
Execute Enzymatica Publ Buy or Sell Advice
The Enzymatica recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Enzymatica publ AB. Macroaxis does not own or have any residual interests in Enzymatica publ AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Enzymatica Publ's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Enzymatica Publ Trading Alerts and Improvement Suggestions
| Enzymatica publ AB generated a negative expected return over the last 90 days | |
| Enzymatica publ AB may become a speculative penny stock | |
| Enzymatica publ AB has high historical volatility and very poor performance | |
| The company reported the revenue of 57.24 M. Net Loss for the year was (45.39 M) with profit before overhead, payroll, taxes, and interest of 33.35 M. | |
| Enzymatica publ AB has accumulated about 64.82 M in cash with (35.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Roughly 64.0% of the company shares are held by company insiders |
Enzymatica Publ Returns Distribution Density
The distribution of Enzymatica Publ's historical returns is an attempt to chart the uncertainty of Enzymatica Publ's future price movements. The chart of the probability distribution of Enzymatica Publ daily returns describes the distribution of returns around its average expected value. We use Enzymatica publ AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Enzymatica Publ returns is essential to provide solid investment advice for Enzymatica Publ.
| Mean Return | -0.41 | Value At Risk | -4.5 | Potential Upside | 4.40 | Standard Deviation | 3.30 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Enzymatica Publ historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Enzymatica Publ Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Enzymatica Publ or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Enzymatica Publ's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Enzymatica stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.41 | |
β | Beta against Dow Jones | -0.02 | |
σ | Overall volatility | 3.06 | |
Ir | Information ratio | -0.16 |
Enzymatica Publ Volatility Alert
Enzymatica publ AB exhibits very low volatility with skewness of 0.27 and kurtosis of 1.38. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Enzymatica Publ's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Enzymatica Publ's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Enzymatica Publ Fundamentals Vs Peers
Comparing Enzymatica Publ's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Enzymatica Publ's direct or indirect competition across all of the common fundamentals between Enzymatica Publ and the related equities. This way, we can detect undervalued stocks with similar characteristics as Enzymatica Publ or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Enzymatica Publ's fundamental indicators could also be used in its relative valuation, which is a method of valuing Enzymatica Publ by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Enzymatica Publ to competition |
| Fundamentals | Enzymatica Publ | Peer Average |
| Return On Equity | -0.4 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Profit Margin | (1.12) % | (1.27) % |
| Operating Margin | (1.12) % | (5.51) % |
| Current Valuation | 613.36 M | 16.62 B |
| Shares Outstanding | 164.26 M | 571.82 M |
| Shares Owned By Insiders | 64.15 % | 10.09 % |
| Shares Owned By Institutions | 1.71 % | 39.21 % |
| Price To Earning | (6.00) X | 28.72 X |
| Price To Book | 47.25 X | 9.51 X |
| Price To Sales | 14.29 X | 11.42 X |
| Revenue | 57.24 M | 9.43 B |
| Gross Profit | 33.35 M | 27.38 B |
| EBITDA | (38.19 M) | 3.9 B |
| Net Income | (45.39 M) | 570.98 M |
| Cash And Equivalents | 64.82 M | 2.7 B |
| Cash Per Share | 0.44 X | 5.01 X |
| Total Debt | 1.12 M | 5.32 B |
| Debt To Equity | 0.11 % | 48.70 % |
| Current Ratio | 2.08 X | 2.16 X |
| Book Value Per Share | 0.91 X | 1.93 K |
| Cash Flow From Operations | (35.87 M) | 971.22 M |
| Earnings Per Share | (0.37) X | 3.12 X |
| Target Price | 7.0 | |
| Number Of Employees | 23 | 18.84 K |
| Beta | 0.088 | -0.15 |
| Market Capitalization | 681.8 M | 19.03 B |
| Total Asset | 157.04 M | 29.47 B |
| Working Capital | 64 M | 1.48 B |
| Current Asset | 81 M | 9.34 B |
| Current Liabilities | 17 M | 7.9 B |
| Net Asset | 157.04 M |
Enzymatica Publ Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Enzymatica . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 6334.2 | |||
| Daily Balance Of Power | 0.7 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 1.69 | |||
| Day Typical Price | 1.71 | |||
| Price Action Indicator | 0.085 | |||
| Period Momentum Indicator | 0.07 |
About Enzymatica Publ Buy or Sell Advice
When is the right time to buy or sell Enzymatica publ AB? Buying financial instruments such as Enzymatica Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Enzymatica Publ in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Dividend Beast Thematic Idea Now
Dividend Beast
An experimental equal-weighted theme of equities with high dividend yield and solid fundamentals based on Macroaxis rating system. The Dividend Beast theme has 69 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Dividend Beast Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Enzymatica Stock Analysis
When running Enzymatica Publ's price analysis, check to measure Enzymatica Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzymatica Publ is operating at the current time. Most of Enzymatica Publ's value examination focuses on studying past and present price action to predict the probability of Enzymatica Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzymatica Publ's price. Additionally, you may evaluate how the addition of Enzymatica Publ to your portfolios can decrease your overall portfolio volatility.